LncRNA HLA Complex Group 11 Knockdown Alleviates Cisplatin Resistance in Gastric Cancer by Targeting the miR-144-3p/UBE2D1 Axis [Retraction]
Li Y, Wang L, Xu X, Sun H, Wu L. Cancer Manag Res. 2021;13:7543–7557. We, the Editors and Publisher of Cancer Management and Research, have retracted the following article. Since publication, concerns have been raised about the integrity of the data in the article. This includes the dupli...
Main Authors: | Li Y, Wang L, Xu X, Sun H, Wu L |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-09-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/retraction-lncrna-hla-complex-group-11-knockdown-alleviates-cisplatin--peer-reviewed-fulltext-article-CMAR |
Similar Items
-
LncRNA RNF144A-AS1 gene polymorphisms and their influence on lung cancer patients in the Chinese Han population
by: Hongjiao Wu, et al.
Published: (2025-02-01) -
UBE2S and UBE2C confer a poor prognosis to breast cancer via downregulation of Numb
by: Yanjing Guo, et al.
Published: (2023-02-01) -
The role of miRNA and lncRNA in heterotopic ossification pathogenesis
by: Łukasz Pulik, et al.
Published: (2022-12-01) -
The lncRNA UBE2R2-AS1 suppresses cervical cancer cell growth in vitro
by: Liu Chunyan, et al.
Published: (2020-11-01) -
The function and clinical relevance of lncRNA UBE2CP3-001 in human gliomas
by: Zhengxiang Luo, et al.
Published: (2018-10-01)